Azurity Pharmaceuticals India LLP
About Azurity Pharmaceuticals India LLP
Data last updated:
Azurity Pharmaceuticals India LLP is a limited liability partnership (LLP) based in Hyderabad, Telangana, India. It operates in the pharma contract r and d segment of the pharmaceuticals sector. It was incorporated on 17 March 2017 and has been in existence for over 9 years.
The LLP is registered with the Registrar of Companies (ROC), Hyderabad, under LLPIN AAI-8691. Its GSTIN is 36ADHFS7360P1ZA (Telangana).
The LLP has a total obligation of contribution of ₹3.24 Lakh. It is led by designated partners including Ronald Lee Scarboro and Sumeet Ashokkumar Wadhwani.
Its latest statement of accounts is for the year ended 31 March 2025. The registered office is at Hyderabad, Telangana.
The LLP has about 117 employees on its provident fund (EPFO) records.
- EmailLocked
- TelephoneLocked
- WebsiteLocked
- Social MediaLocked
- Registered Address9th Floor Building No. 2B Mindspace, Cyberabad Hitech City, Hyderabad, Telangana, India – 500081
- IndustryPharma, Pharma Contract R&D
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Financials of Azurity Pharmaceuticals India LLP FY 2025 filings available
Financial Statement Summary of Azurity Pharmaceuticals India LLP
| Statement of Account and Solvency | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Income and Expenditure | |||||
| Turnover | •••• | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• | •••• |
| Total Income | •••• | •••• | •••• | •••• | •••• |
| Purchases and Direct Costs | •••• | •••• | •••• | •••• | •••• |
| Personnel Expenses | •••• | •••• | •••• | •••• | •••• |
| Administrative Expenses | •••• | •••• | •••• | •••• | •••• |
| Interest | •••• | •••• | •••• | •••• | •••• |
| Depreciation | •••• | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• | •••• |
| Tax | •••• | •••• | •••• | •••• | •••• |
| Profit After Tax | •••• | •••• | •••• | •••• | •••• |
| Profit Transferred to Partners | •••• | •••• | •••• | •••• | •••• |
| Assets and Liabilities | |||||
| Partners' Contribution | •••• | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• | •••• |
| Secured Loans | •••• | •••• | •••• | •••• | •••• |
| Unsecured Loans | •••• | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• | •••• |
| Other Liabilities and Provisions | •••• | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• | •••• |
| Loans and Advances | •••• | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• | •••• |
Financial Ratios of Azurity Pharmaceuticals India LLP
| Statement of Account and Solvency | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| Net Profit Margin | •••• | •••• | •••• | •••• | •••• |
| Return on Partners' Funds | •••• | •••• | •••• | •••• | •••• |
| Return on Assets | •••• | •••• | •••• | •••• | •••• |
| Liquidity and Debt | |||||
| Current Ratio | •••• | •••• | •••• | •••• | •••• |
| Debt to Partners' Funds | •••• | •••• | •••• | •••• | •••• |
| Interest Coverage | •••• | •••• | •••• | •••• | •••• |
| Efficiency and Growth | |||||
| Asset Turnover | •••• | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• | •••• |
| Turnover Growth | •••• | •••• | •••• | •••• | •••• |
| Profit Growth | •••• | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form 8. The full year-wise statements and ratios of Azurity Pharmaceuticals India are in the company report.
Financial statements from FY 2017
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Designated Partners of Azurity Pharmaceuticals India LLP
Azurity Pharmaceuticals India has 3 current designated partners and 4 former designated partners. Current designated partners are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Ronald Lee Scarboro | Designated Partner | 20 Nov 2024 | 1 Years 10 Months | Current |
| Sumeet Ashokkumar Wadhwani | Designated Partner | 20 Nov 2024 | 1 Years 10 Months | Current |
| George Hanok Mathew | Designated Partner | 20 Nov 2024 | 1 Years 10 Months | Current |
Charges & Borrowings of Azurity Pharmaceuticals India LLP
Azurity Pharmaceuticals India LLP does not have any charges (loans) registered with the Registrar of Companies.
Employees and EPFO Compliance at Azurity Pharmaceuticals India LLP
Employment history and EPFO contributions of people linked to Azurity Pharmaceuticals India.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Recent Activity on Azurity Pharmaceuticals India LLP
Azurity Pharmaceuticals India LLP has 10 designated partner changes on record since 2017: 6 appointments and 4 cessations. The latest: Ajay Singh Kumar ceased to be Designated Partner on 03 Dec 2024.
1 earlier event is listed in the company report.
Credit Ratings, Litigation & Regulatory Alerts for Azurity Pharmaceuticals India LLP
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Azurity Pharmaceuticals India LLP
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Azurity Pharmaceuticals India LLP
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Azurity Pharmaceuticals India LLP
Azurity Pharmaceuticals India has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 36ADHFS7360P1ZA | Telangana | Active | 01 Jul 2017 |
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Azurity Pharmaceuticals India LLP
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Azurity Pharmaceuticals India LLP
Azurity Pharmaceuticals India is an active limited liability partnership based in Hyderabad, Telangana, India. The LLP works in pharma contract r and d, within the pharma industry. It was incorporated on 17 March 2017 (9+ years old) and is registered under LLPIN AAI-8691.
Azurity Pharmaceuticals India has 3 current designated partners:
- Ronald Lee Scarboro - Designated Partner
- Sumeet Ashokkumar Wadhwani - Designated Partner
- George Hanok Mathew - Designated Partner
The GSTIN of Azurity Pharmaceuticals India is 36ADHFS7360P1ZA, registered in Telangana.
The LLPIN (Limited Liability Partnership Identification Number) of Azurity Pharmaceuticals India is AAI-8691. It is issued by the Ministry of Corporate Affairs and uniquely identifies the LLP in India.
Azurity Pharmaceuticals India was incorporated on 17 March 2017, making it 9+ years old. It is registered with the Registrar of Companies, Hyderabad.
Ajay Singh Kumar ceased to be Designated Partner on 03 Dec 2024. Gyan Ranjan Singh ceased to be Designated Partner on 03 Dec 2024. Sowmen Sushilkumar Porel ceased to be Designated Partner on 03 Dec 2024. Azurity Pharmaceuticals India has 10 designated partner changes on record in total.
The registered office of Azurity Pharmaceuticals India is at 9th Floor Building No. 2B Mindspace, Cyberabad Hitech City, Hyderabad, Telangana, India – 500081.
The total obligation of contribution is ₹3.24 Lakh.
Azurity Pharmaceuticals India operates in the pharma industry, in the pharma contract r and d segment.
Azurity Pharmaceuticals India has about 117 employees on its provident fund (EPFO) records, the latest count available.